|
BCLAF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.4696247531183E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.00339994488519E-09 |
| Normal-vs-Stage2 |
7.55640000016378E-07 |
| Normal-vs-Stage3 |
7.31992244595858E-12 |
| Normal-vs-Stage4 |
9.30544530319821E-12 |
| Stage1-vs-Stage2 |
4.770000E-01 |
| Stage1-vs-Stage3 |
3.726000E-02 |
| Stage1-vs-Stage4 |
4.517400E-03 |
| Stage2-vs-Stage3 |
4.533000E-01 |
| Stage2-vs-Stage4 |
2.108600E-01 |
| Stage3-vs-Stage4 |
4.500600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.232414749898E-12 |
| Normal-vs-AfricanAmerican |
7.639400E-04 |
| Normal-vs-Asian |
6.56580000368834E-08 |
| Caucasian-vs-AfricanAmerican |
3.309400E-01 |
| Caucasian-vs-Asian |
8.660200E-01 |
| AfricanAmerican-vs-Asian |
3.907800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.45403697363145E-12 |
| Normal-vs-Female |
1.69700031804609E-10 |
| Male-vs-Female |
2.414600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.86370000543334E-08 |
| Normal-vs-Age(41-60Yrs) |
1.57780011278419E-10 |
| Normal-vs-Age(61-80Yrs) |
2.94470003936453E-11 |
| Normal-vs-Age(81-100Yrs) |
1.238860E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.447370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.509500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.577600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.825600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.032400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.546800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.314210E-02 |
| Classical-VS-Follicular |
1.246390E-01 |
| Classical-VS-Other |
1.364620E-01 |
| Classical-VS-Normal |
9.61480006722581E-10 |
| Tall-VS-Follicular |
2.099800E-01 |
| Tall-VS-Other |
8.029400E-01 |
| Tall-VS-Normal |
4.21239998438239E-09 |
| Follicular-VS-Other |
4.747600E-01 |
| Follicular-VS-Normal |
3.93629999706491E-08 |
| Other-VS-Normal |
4.628600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.56109602811716E-11 |
| Normal-vs-N1 |
3.14990000749304E-09 |
| N0-vs-N1 |
4.673800E-01 |
|
|
